Your browser doesn't support javascript.
loading
Correlation Between the Distance to Mesorectal Fascia and Prognosis of cT3 Rectal Cancer: Results of a Multicenter Study From China.
Zhang, Xiao-Yan; Li, Xiao-Ting; Shi, Yan-Jie; Lu, Qiao-Yuan; Cao, Wuteng; Zhang, Hong-Mei; Wang, Lin; Zhu, Hai-Tao; Yu, Tao; Guan, Zhen; Sun, Rui-Jia; Zhu, Hai-Bin; Wu, Ai-Wen; Sun, Ying-Shi.
Afiliação
  • Zhang XY; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Hai Dian District, Beijing, China.
  • Li XT; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Hai Dian District, Beijing, China.
  • Shi YJ; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Hai Dian District, Beijing, China.
  • Lu QY; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Hai Dian District, Beijing, China.
  • Cao W; Department of Radiology, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Zhang HM; Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China.
  • Wang L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Hai Dian District, Beijing, China.
  • Zhu HT; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Hai Dian District, Beijing, China.
  • Yu T; Department of Medical Imaging, Cancer Hospital of China Medical University, Dadong District, Shenyang, Liaoning Province, China.
  • Guan Z; Department of Medical Imaging, Liaoning Cancer Hospital & Institute, Dadong District, Shenyang, Liaoning Province, China.
  • Sun RJ; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Hai Dian District, Beijing, China.
  • Zhu HB; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Hai Dian District, Beijing, China.
  • Wu AW; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Hai Dian District, Beijing, China.
  • Sun YS; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Hai Dian District, Beijing, China.
Dis Colon Rectum ; 65(3): 322-332, 2022 03 01.
Article em En | MEDLINE | ID: mdl-34459446
ABSTRACT

BACKGROUND:

The cT3 substage criteria based on extramural depth of tumor invasion in rectal cancer have several limitations.

OBJECTIVE:

This study proposed that the distance between the deepest tumor invasion and mesorectal fascia on pretherapy MRI can distinguish the prognosis of patients with cT3 rectal cancer.

DESIGN:

This is a cohort study.

SETTING:

This study included a prospective, single-center, observational cohort and a retrospective, multicenter, independent validation cohort. PATIENT Patients who had cT3 rectal cancer with negative mesorectal fascia undergoing neoadjuvant chemoradiotherapy followed by radical surgery were included in 4 centers in China from January 2013 to September 2014. INTERVENTION Baseline MRI with the distance between the deepest tumor invasion and mesorectal fascia, extramural depth of tumor invasion, and mesorectum thickness were measured. MAIN OUTCOME

MEASURES:

The cutoff of the distance between the deepest tumor invasion and mesorectal fascia was determined by time-dependent receiver operating characteristic curves, supported by a 5-year progression rate from the prospective cohort, and was then validated in a retrospective cohort.

RESULTS:

There were 124 and 274 patients included in the prospective and independent validation cohorts. The distance between the deepest tumor invasion and mesorectal fascia was the only predictor for cancer-specific death (HR, 0.1; 95% CI, 0.0-0.7) and was also a significant predictor for distant recurrence (HR, 0.4; 95% CI, 0.2-0.9). No statistically significant difference was observed in prognosis between patients classified as T3a/b and T3c/d.

LIMITATIONS:

The sample size is relatively small, and the study focused on cT3 rectal cancers with a negative mesorectal fascia.

CONCLUSIONS:

A cutoff of 7 mm of the distance between the deepest tumor invasion and mesorectal fascia on baseline MRI can distinguish cT3 rectal cancer from a different prognosis. We recommend using the distance between the deepest tumor invasion and mesorectal fascia on baseline MRI for local and systemic risk assessment and providing a tailored schedule of neoadjuvant treatment. See Video Abstract at http//links.lww.com/DCR/B682.CORRELACIÓN ENTRE LA DISTANCIA DE LA FASCIA MESORRECTAL Y EL PRONÓSTICO DEL CÁNCER DE RECTO cT3 RESULTADOS DE UN ESTUDIO MULTICÉNTRICO DE CHINAANTECEDENTESLos criterios de subestadificación cT3 basados en la profundidad extramural de invasión tumoral en el cáncer de recto tienen varias limitaciones.

OBJETIVO:

Este estudio propuso que la distancia entre la invasión tumoral más profunda y la fascia mesorrectal en la resonancia magnética preterapia puede distinguir el pronóstico de los pacientes con cT3.

DISEÑO:

Estudio de cohorte.ENTORNO CLINICOEl estudio incluyó una cohorte observacional, prospectiva, unicéntrica, y una cohorte de validación retrospectiva, multicéntrica e independiente.PACIENTESe incluyeron pacientes con cáncer de recto cT3 con fascia mesorrectal negativa sometidos a quimio-radioterapia neoadyuvante seguida de cirugía radical en cuatro centros de China desde enero de 2013 hasta septiembre de 2014.INTERVENCIÓNImágenes de resonancia magnética de referencia fueron medidas con la distancia entre la invasión tumoral más profunda y la fascia mesorrectal; la profundidad extramural de la invasión tumoral y el grosor del mesorrecto.PRINCIPALES MEDIDAS DE VALORACIONEl límite de la distancia entre la invasión tumoral más profunda y la fascia mesorrectal se determinó mediante curvas características operativas del receptor dependientes del tiempo y se apoyó en la tasa de progresión a 5 años de la cohorte prospectiva, y luego se validó en una cohorte retrospectiva.

RESULTADOS:

Se incluyeron 124 y 274 pacientes en la cohorte de validación prospectiva e independiente, respectivamente. La distancia entre la invasión tumoral más profunda de la fascia mesorrectal fue el único predictor de muerte específica por cáncer (Hazard ratio 0.1, 95% CI, 0,0-0,7); y también fue un predictor significativo de recurrencia distante Hazard ratio 0,4, 95% CI, 0,2-0,9). No se observaron diferencias estadísticamente significativas en el pronóstico entre los pacientes clasificados como T3a/b y T3c/d.LIMITACIONESEl tamaño de la muestra es relativamente pequeño y el estudio se centró en los cánceres de recto cT3 con fascia mesorrectal negativa.

CONCLUSIONES:

Un límite de 7 mm de distancia entre la invasión tumoral más profunda y la fascia mesorrectal en la resonancia magnética de referencia puede distinguir el cáncer de recto cT3 de diferentes pronósticos. Recomendamos la distancia entre la invasión tumoral más profunda y la fascia mesorrectal en la resonancia magnética de referencia para la evaluación del riesgo local y sistémico, proporcionando un programa personalizado de tratamiento neoadyuvante. Consulte Video Resumen en http//links.lww.com/DCR/B682. (Traducción- Dr. Francisco M. Abarca-Rendon).
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Reto / Imageamento por Ressonância Magnética / Protectomia / Invasividade Neoplásica Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Dis Colon Rectum Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Reto / Imageamento por Ressonância Magnética / Protectomia / Invasividade Neoplásica Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Dis Colon Rectum Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China